On 16 April 2026 the FDA removed BPC-157 and 11 other peptides from Category 2, and a Pharmacy Compounding Advisory Committee (PCAC) hearing on 23 and 24 July 2026 is now reviewing whether to add BPC-157, alongside TB-500, KPV, MOTS-C, DSIP, Semax and Epitalon, to the 503A "positive bulks list" (see our FDA PCAC July 2026 explainer)
Leading Glutathione Supplements Manufacturers and Suppliers The global glutathione supplements market is characterized by a mix of established and emerging players, indicating a moderately fragmented landscape
FAQ If I could only choose one, BPC-157 or TB-500
Never share needles, syringes, or multi-dose vials with another person
These capsules do, however, contain lecithin derived from soybeans (a potential allergen) as an emulsifier, and they also use gelatin, so may not be Halal nor suitable for vegetarians
Its impact on circulation and cellular signaling allows a broader control of inflammation